It was recently shown that MUC16 silencing in breast cancer cells is associated with up-regulation of TRAIL-R1 (DR4) and pro-apoptotic molecules Bid and Bax, and down-regulation of Bcl-2 [43]. This evidence concerns the gene TNFRSF10A and breast cancer.